Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 39.74% is 29% above its 5-year average of 30.92%, near the high end of its 5-year range (-133.21%–51.77%).
923.13% above its 12-month average of 3.88%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -133.21%.
OPERATING MARGIN
39.74%
OPERATING MARGIN AVG TTM
3.88%
OPERATING MARGIN AVG 3Y
32.13%
OPERATING MARGIN AVG 5Y
30.92%
OPERATING MARGIN AVG 10Y
37.35%
OPERATING MARGIN AVG 15Y
43.16%
OPERATING MARGIN AVG 20Y
44.91%
CURRENT VS TTM AVG
+923.13%
CURRENT VS 3Y AVG
+23.67%
CURRENT VS 5Y AVG
+28.51%
CURRENT VS 10Y AVG
+6.41%
CURRENT VS 15Y AVG
-7.92%
CURRENT VS 20Y AVG
-11.51%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+166.71%
vs the sector median at left
Gilead Sciences, Inc.
Market Cap
$183.36B
Operating Margin
39.74%
TTM Avg
3.88%
3Y Avg
32.13%
5Y Avg
30.92%
Market Cap
$185.26B
Operating Margin
43.10%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
Market Cap
$177.12B
Operating Margin
17.03%
TTM Avg
17.21%
3Y Avg
17.41%
5Y Avg
17.71%
Market Cap
$146.59B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$135.05B
Operating Margin
31.28%
TTM Avg
28.70%
3Y Avg
26.89%
5Y Avg
27.25%
Market Cap
$130.27B
Operating Margin
38.59%
TTM Avg
18.66%
3Y Avg
31.09%
5Y Avg
34.52%
Market Cap
$129.92B
Operating Margin
28.27%
TTM Avg
24.24%
3Y Avg
21.84%
5Y Avg
19.75%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $183.36B | 39.74% | 3.88% | 32.13% | 30.92% |
| Novo Nordisk A/S (NVO)vs › | $185.26B | 43.10% | 42.74% | 42.98% | 42.70% |
| Abbott Laboratories (ABT)vs › | $177.12B | 17.03% | 17.21% | 17.41% | 17.71% |
| Amgen Inc. (AMGN)vs › | $203.12B | 33.18% | 25.38% | 28.78% | 30.08% |
| Pfizer Inc. (PFE)vs › | $156.51B | 25.08% | 25.29% | 24.23% | 24.05% |
| Danaher Corporation (DHR)vs › | $146.59B | 20.42% | 21.31% | 23.25% | 23.28% |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.05B | 31.28% | 28.70% | 26.89% | 27.25% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.27B | 38.59% | 18.66% | 31.09% | 34.52% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.92B | 28.27% | 24.24% | 21.84% | 19.75% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $240.97B | 17.69% | 18.04% | 18.11% | 20.54% |
Gross Margin
79.6%
Operating Margin
39.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -133.21% |
| 2026-03-31 | 37.16% |
| 2025-12-31 | 37.71% |
| 2025-09-30 | 42.82% |
| 2025-06-30 | 34.94% |
| 2025-03-31 | 33.55% |
| 2024-12-31 | 32.40% |
| 2024-09-30 | 11.77% |
| 2024-06-30 | 38.03% |
| 2024-03-31 | -64.64% |
| 2023-12-31 | 22.66% |
| 2023-09-30 | 37.21% |
| 2023-06-30 | 25.23% |
| 2023-03-31 | 26.84% |
| 2022-12-31 | 30.68% |
| 2022-09-30 | 40.29% |
| 2022-06-30 | 32.41% |
| 2022-03-31 | 2.99% |
| 2021-12-31 | 12.98% |
| 2021-09-30 | 51.77% |
| 2021-06-30 | 36.13% |
| 2021-03-31 | 44.99% |
| 2020-12-31 | 35.72% |
| 2020-09-30 | 30.42% |
| 2020-06-30 | -58.00% |
| 2020-03-31 | 43.29% |
| 2019-12-31 | 18.59% |
| 2019-09-30 | -26.28% |
| 2019-06-30 | 42.74% |
| 2019-03-31 | 42.36% |
| 2018-12-31 | 19.74% |
| 2018-09-30 | 46.87% |
| 2018-06-30 | 40.37% |
| 2018-03-31 | 42.32% |
| 2017-12-31 | 38.51% |
| 2017-09-30 | 58.54% |
| 2017-06-30 | 59.57% |
| 2017-03-31 | 57.91% |
| 2016-12-31 | 55.26% |
| 2016-09-30 | 58.65% |
| 2016-06-30 | 58.36% |
| 2016-03-31 | 59.67% |
| 2015-12-31 | 66.08% |
| 2015-09-30 | 67.33% |
| 2015-06-30 | 68.12% |
| 2015-03-31 | 70.73% |
| 2014-12-31 | 59.20% |
| 2014-09-30 | 57.60% |
| 2014-06-30 | 67.51% |
| 2014-03-31 | 60.87% |
| 2013-12-31 | 38.37% |
| 2013-09-30 | 41.25% |
| 2013-06-30 | 41.69% |
| 2013-03-31 | 40.50% |
| 2012-12-31 | 42.77% |
| 2012-09-30 | 43.02% |
| 2012-06-30 | 44.03% |
| 2012-03-31 | 35.06% |
| 2011-12-31 | 39.42% |
| 2011-09-30 | 47.31% |
| 2011-06-30 | 47.57% |
| 2011-03-31 | 46.83% |
| 2010-12-31 | 41.50% |
| 2010-09-30 | 50.53% |
| 2010-06-30 | 51.51% |
| 2010-03-31 | 55.67% |
| 2009-12-31 | 52.42% |
| 2009-09-30 | 49.65% |
| 2009-06-30 | 46.20% |
| 2009-03-31 | 52.82% |
| 2008-12-31 | 49.79% |
| 2008-09-30 | 50.60% |
| 2008-06-30 | 47.38% |
| 2008-03-31 | 53.10% |
| 2007-12-31 | 47.00% |
| 2007-09-30 | 51.66% |
| 2007-06-30 | 51.79% |
| 2007-03-31 | 54.47% |
| 2006-12-31 | -172.73% |
| 2006-09-30 | 7.68% |
| 2006-06-30 | 53.31% |
| 2006-03-31 | 53.64% |
| 2005-12-31 | 59.42% |
| 2005-09-30 | 50.31% |
| 2005-06-30 | 56.03% |
| 2005-03-31 | 51.92% |
| 2004-12-31 | 44.73% |
| 2004-09-30 | 50.21% |
| 2004-06-30 | 49.48% |
| 2004-03-31 | 46.72% |
| 2003-12-31 | 33.39% |
| 2003-09-30 | 39.51% |
| 2003-06-30 | 45.12% |
| 2003-03-31 | -262.62% |
| 2002-12-31 | 22.64% |
| 2002-09-30 | 26.81% |
